Glucotrack Reports Unregistered Equity Sale
Ticker: GCTK · Form: 8-K · Filed: Sep 10, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $259,300.00, $0.001, $1.02, $1.875, $2.625 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities
TL;DR
Glucotrack sold unregistered stock, details TBD.
AI Summary
Glucotrack, Inc. reported on September 5, 2024, an unregistered sale of equity securities. The filing does not disclose specific details regarding the number of shares sold, the price, or the purchasers involved in this transaction.
Why It Matters
Unregistered sales can sometimes indicate financing needs or strategic partnerships, but the lack of detail makes it difficult to assess the immediate impact.
Risk Assessment
Risk Level: medium — Unregistered sales can be a sign of financial distress or dilution, and the lack of specific details in this filing increases uncertainty.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- September 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41141 (identifier) — SEC File Number
- 98-0668934 (identifier) — IRS Employer Identification No.
- 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 (address) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the type of securities.
How many shares were sold in this unregistered offering?
The filing does not provide the number of shares sold.
What was the price per share or total consideration for the unregistered sale?
The filing does not disclose the price per share or the total amount of consideration received.
Who were the purchasers of these unregistered equity securities?
The filing does not identify the purchasers of the unregistered equity securities.
What is the purpose of this unregistered sale of equity securities?
The filing does not state the purpose for the unregistered sale of equity securities.
Filing Stats: 707 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-09-10 16:15:12
Key Financial Figures
- $259,300.00 — Company agreed to convert approximately $259,300.00 of debt (the "Debt") held by the Invest
- $0.001 — the Investor to common stock, par value $0.001 per share of the Company (the "common s
- $1.02 — common stock") at a conversion price of $1.02 per share. Also in satisfaction of th
- $1.875 — shares of common stock, exercisable at $1.875 per share. The second Warrant is for 98
- $2.625 — shares of common stock, exercisable at $2.625 per share. The third Warrant is for 76,
- $3.375 — shares of common stock, exercisable at $3.375 per share. The Warrants are subject to
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-035631.txt ( ) — 208KB
- gctk-20240905.xsd (EX-101.SCH) — 3KB
- gctk-20240905_lab.xml (EX-101.LAB) — 33KB
- gctk-20240905_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 10, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer